The company is molecule drug discovery, and development company. The focus is on emerging epigenetic cancer targets. They are focused on emerging targets where they can be first in class. The company has a strong team of experts in epigenetics biology.

Posted Jul 18, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.